Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents - PubMed (original) (raw)
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents
Saïd Abes et al. J Control Release. 2006.
Abstract
The efficient and non-toxic nuclear delivery of steric-block oligonucleotides (ON) is a prerequisite for therapeutic strategies involving splice correction or exon skipping. Cationic cell penetrating peptides (CPPs) have given rise to much interest for the intracellular delivery of biomolecules, but their efficiency in promoting cytoplasmic or nuclear delivery of oligonucleotides has been hampered by endocytic sequestration and subsequent degradation of most internalized material in endocytic compartments. In the present study, we compared the splice correction activity of three different CPPs conjugated to PMO(705), a steric-block ON targeted against the mutated splicing site of human beta-globin pre-mRNA in the HeLa pLuc705 splice correction model. In contrast to Tat48-60 (Tat) and oligoarginine (R(9)F(2)) PMO(705) conjugates, the 6-aminohexanoic-spaced oligoarginine (R-Ahx-R)(4)-PMO(705) conjugate was able to promote an efficient splice correction in the absence of endosomolytic agents. Our mechanistic investigations about its uptake mechanisms lead to the conclusion that these three vectors are internalized using the same endocytic route involving proteoglycans, but that the (R-Ahx-R)(4)-PMO(705) conjugate has the unique ability to escape from lysosomial fate and to access to the nuclear compartment. This vector, which has displays an extremely low cytotoxicity, the ability to function without chloroquine adjunction and in the presence of serum proteins. It thus offers a promising lead for the development of vectors able to enhance the delivery of therapeutic steric-block ON in clinically relevant models.
Similar articles
- Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S, Johansson HJ, Lundberg P, Langel U. El-Andaloussi S, et al. J Gene Med. 2006 Oct;8(10):1262-73. doi: 10.1002/jgm.950. J Gene Med. 2006. PMID: 16900561 - Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
Moulton HM, Fletcher S, Neuman BW, McClorey G, Stein DA, Abes S, Wilton SD, Buchmeier MJ, Lebleu B, Iversen PL. Moulton HM, et al. Biochem Soc Trans. 2007 Aug;35(Pt 4):826-8. doi: 10.1042/BST0350826. Biochem Soc Trans. 2007. PMID: 17635157 Review. - Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM. Youngblood DS, et al. Bioconjug Chem. 2007 Jan-Feb;18(1):50-60. doi: 10.1021/bc060138s. Bioconjug Chem. 2007. PMID: 17226957 - Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
Wolf Y, Pritz S, Abes S, Bienert M, Lebleu B, Oehlke J. Wolf Y, et al. Biochemistry. 2006 Dec 19;45(50):14944-54. doi: 10.1021/bi0606896. Biochemistry. 2006. PMID: 17154532 - Cell penetrating peptide conjugates of steric block oligonucleotides.
Lebleu B, Moulton HM, Abes R, Ivanova GD, Abes S, Stein DA, Iversen PL, Arzumanov AA, Gait MJ. Lebleu B, et al. Adv Drug Deliv Rev. 2008 Mar 1;60(4-5):517-29. doi: 10.1016/j.addr.2007.09.002. Epub 2007 Oct 22. Adv Drug Deliv Rev. 2008. PMID: 18037527 Free PMC article. Review.
Cited by
- Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA.
Sakai A, Singh G, Khoshbakht M, Bittner S, Löhr CV, Diaz-Tapia R, Warang P, White K, Luo LL, Tolbert B, Blanco M, Chow A, Guttman M, Li C, Bao Y, Ho J, Maurer-Stroh S, Chatterjee A, Chanda S, García-Sastre A, Schotsaert M, Teijaro JR, Moulton HM, Stein DA. Sakai A, et al. Mol Ther Nucleic Acids. 2024 Sep 10;35(4):102331. doi: 10.1016/j.omtn.2024.102331. eCollection 2024 Dec 10. Mol Ther Nucleic Acids. 2024. PMID: 39376996 Free PMC article. - Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10.
Auger M, Sorroza-Martinez L, Brahiti N, Huppé CA, Faucher-Giguère L, Arbi I, Hervault M, Cheng X, Gaillet B, Couture F, Guay D, Soultan AH. Auger M, et al. Mol Ther Nucleic Acids. 2024 Jul 31;35(3):102290. doi: 10.1016/j.omtn.2024.102290. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39233851 Free PMC article. - Cyclization increases bactericidal activity of arginine-rich cationic cell-penetrating peptide for Neisseria gonorrhoeae.
John CM, Otala SA, Jarvis GA. John CM, et al. Microbiol Spectr. 2024 Sep 3;12(9):e0099724. doi: 10.1128/spectrum.00997-24. Epub 2024 Aug 6. Microbiol Spectr. 2024. PMID: 39105587 Free PMC article. - ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
Heindl MR, Rupp A-L, Schwerdtner M, Bestle D, Harbig A, De Rocher A, Schmacke LC, Staker B, Steinmetzer T, Stein DA, Moulton HM, Böttcher-Friebertshäuser E. Heindl MR, et al. J Virol. 2024 Apr 16;98(4):e0010224. doi: 10.1128/jvi.00102-24. Epub 2024 Mar 12. J Virol. 2024. PMID: 38470058 Free PMC article. - Promising strategies employing nucleic acids as antimicrobial drugs.
Moreira L, Guimarães NM, Santos RS, Loureiro JA, Pereira MC, Azevedo NF. Moreira L, et al. Mol Ther Nucleic Acids. 2024 Jan 18;35(1):102122. doi: 10.1016/j.omtn.2024.102122. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38333674 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous